A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

PHASE2UnknownINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2015

Conditions
Malignant Pleural Mesothelioma
Interventions
DRUG

ADI-PEG 20

36.8mg/m2 based on BSA, weekly treatment for 6 months

Trial Locations (7)

BN2 5BE

The Royal Sussex County Hospital, Brighton

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge

HU8 9HE

Hull and East Yorkshire Hospitals NHS Trust,The Princess Royal Hospital, Hull

EC1 A 7BE

Barts and The London NHS, St Bartholomew's Hospital, London

SE1 9RT

Guy's and St Thomas' Foundation Trust, Guy's Hospital, London

M23 9LT

University Hospital of South Manchester NHS Foundation Trust, Wythenshawe Hospital, Manchester

SO16 6 YD

Southampton University Hospitals NHS Trust, Southampton General Hospital, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

UK: Barts Center for Experimental Cancer Medicine (CECM) for Trial Coordination

UNKNOWN

lead

Barts & The London NHS Trust

OTHER